Change in Fiscal Year End

1 Months Ended

Jan. 31, 2015

Change in Fiscal Year End

CHANGE IN FISCAL YEAR END

1. CHANGE IN FISCAL YEAR END

On March 26, 2015, the board of directors of BioPharmX Corporation approved a change in our fiscal year end from December 31 to January 31.  As a result of this change the Company is filing this Transition Report on Form 10-K for the one-month transition period ended January 31, 2015.  Corresponding results for the years ended December 31, 2014 and 2013 are both for 12 month periods.  In addition, the consolidated statements of operations and comprehensive loss and cash flows also include an unaudited one-month period ended January 31, 2014.